Commodore Capital is a fund manager in New York with $538.69 mm assets under management.
Company profile
Website
Employees
Incorporated
Fiscal year end
Industry
SEC CIK
IRS number
832659606
SEC advisor number
801-117168
FINRA CRD number
304370
AUM ?
$538.69 mm
(as of 19 Dec 22)
Accounts
3
(as of 19 Dec 22)
Employees
8
(5 investment advisory or research)
Office hours
Monday - Friday, 9AM-5PM
Ownership
Owner | Title | From | %Ownership |
---|---|---|---|
Kramarz, Michael, Jonathan | Managing Partner | 06/2019 | < 5% |
Atkinson, Robert Egen, Turrell | Managing Partner | 06/2019 | < 5% |
Glass, Robert, a | Chief Financial Officer | 06/2019 | < 5% |
Commodore Capital GP LLC | General Partner | 06/2019 | < 5% |
Commodore Capital Holdings LP | Limited Partner | 06/2019 | > 75% |
Kramarz, Michael, Jonathan | Limited Partner | 06/2019 | 25-50% |
Atkinson, Robert Egen, Turrell | Limited Partner | 06/2019 | 25-50% |
Kramarz, Michael, Jonathan | Member and Director | 06/2019 | 25-50% |
Atkinson, Robert Egen, Turrell | Member and Director | 06/2019 | 25-50% |
Barakett, Timothy, Robert | Director | 06/2019 | |
Bapat, Ameya, Vikas | Chief Compliance Officer | 03/2022 | < 5% |
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Commodore Capital | $538.69 mm | |
Commodore Capital Master LP | $538.69 mm | Hedge Fund |
Commodore Capital Offshore LTD. | ||
Commodore Capital Domestic LP |
Latest filings (excl ownership)
No filings
Latest ownership filings
SC 13G
Perspective Therapeutics, Inc.
19 Apr 24
SC 13G
Mind Medicine (MindMed) Inc.
21 Mar 24
13F-HR/A
Quarterly holdings report by institutional manager (amended)
14 Feb 24
SC 13G/A
Vera Therapeutics, Inc.
14 Feb 24
SC 13G/A
IMMUNIC, INC.
14 Feb 24
SC 13G/A
Cogent Biosciences, Inc.
14 Feb 24
SC 13G/A
Adverum Biotechnologies, Inc.
14 Feb 24
SC 13G/A
CymaBay Therapeutics, Inc.
14 Feb 24
SC 13G/A
Cabaletta Bio, Inc.
14 Feb 24
SC 13G/A
SOLENO THERAPEUTICS INC
14 Feb 24
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Jan 24 | Commodore Capital | Class A Common Stock | Sell | Dispose S | Yes | No | 18 | 1,050,000 | 18.90 mm | 4,400,000 |
4 Oct 23 | Commodore Capital | Tranche 2 Warrants Common Stock | Grant | Acquire A | Yes | No | 8.877 | 1,690,014 | 15.00 mm | 1,690,014 |
4 Oct 23 | Commodore Capital | Tranche 1 Warrants Common Stock | Grant | Acquire A | Yes | No | 5.38 | 1,394,310 | 7.50 mm | 1,394,310 |
4 Oct 23 | Commodore Capital | Pre-Funded Warrants Common Stock | Grant | Acquire A | Yes | No | 0.001 | 2,788,620 | 2.79 k | 2,788,620 |
7 Aug 23 | Commodore Capital | Common Stock | Buy | Acquire P | Yes | No | 23.153 | 775,756 | 17.96 mm | 1,575,000 |
20 Jun 23 | Commodore Capital | Class A Common Stock | Buy | Acquire P | Yes | No | 15.169 | 448,217 | 6.80 mm | 5,450,000 |